Companion: Sensor-based Two-way Communication for Physical Activity in Older Adults
Completed · Early Phase 1
Conditions studied: Exercise, Physical Activity
In brief
This pilot study is a small sample (N=46) 16-week clinical trial with a follow-up after 24-weeks among sedentary adults \>60 y with a BMI \>25 kg/m2 to tests the impact of a hybrid artificial intelligence behavior change system (Companion) on physical activity. Participants will be randomized to a control and intervention group. All participants will engage in a proven supervised exercise program from week 1 to 16. Only the intervention group will receive Companion from week 1 to 16.
Key facts
- Study ID
- NCT04827212
- Run by
- Northeastern University
- People needed
- 51
- Starts
- 2021-03-16
- Expected to finish
- 2022-12-13
- Last updated by the study team
- 2024-07-03
Who can join
Age: 60 and older, up to 90. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 60 years and above- This intervention study focusses on this population demographic.
- Participants have a body mass index greater than 25 kg/m2- This threshold for BMI is used to classify an adult as overweight or obese
- No conditions preventing participation in physical activity lasting 10 to 30 min- Such conditions will limit prescription of physical activity/exercise components of the training program and that promoted using Companion.
- Have a smart phone- The absence of a smart phone will limit the ability of remote communication with the study participant using Companion.
You may not qualify if…
- Engage in structured physical activity for more than 2 days/week lasting 30 min/session- Physically active participants will not be representative of typical adults >60 y. Being active prior to study participation may mask the effects of the intervention.
- Regularly use any assistive device for walking- Use of an assistive device would limit the ability to engage in prescribed physical activity. Future work can be tailored for sub-groups in the demographic being studied.
- Likely to alter medications pertaining to cardiovascular or metabolic health- Altering medications during the study will influence change in selected outcome measures.
Where it is running
- Northeastern Univeristy — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.